Updated Bivalent Boosters Offer Extra Protection Against COVID-19
Bivalent COVID vaccine efficacy at 6 months: 24% against hospitalization, strong against death | CIDRAP
Boosting with updated COVID-19 mRNA vaccines | Nature Medicine
FDA advisory panel recommends Omicron-containing booster shots
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
Effectiveness of Up-to-Date COVID-19 Vaccination in Preventing SARS-CoV-2 Infection Among Nursing Home Residents — United States, November 20, 2022–January 8, 2023 | MMWR
Durability of Bivalent Boosters against Omicron Subvariants | NEJM
Efficacy of Bivalent Boosters Against Severe Omicron | Latest news for Doctors, Nurses and Pharmacists | Respirology
Comparing the COVID-19 Vaccines: How Are They Different? > News > Yale Medicine
COMPARISON OF COVID 19 VACCINES | Mya Care
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years | Nature Medicine
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
Who Is Eligible for a COVID-19 Booster?
New Omicron-specific vaccines offer similar protection to existing boosters
CDC publishes first estimates of bivalent boosters' effectiveness against XBB.1.5
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial - The Lancet Respiratory Medicine
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
FDA vaccine advisers 'disappointed' and 'angry' that early data about new Covid-19 booster shot wasn't presented for review last year | CNN
Vaccines | Free Full-Text | Efficacy of the Second COVID-19 Vaccine Booster Dose in the Elderly
Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
Evidence to recommendation Framework: Bivalent COVID-19 vaccine booster doses
